This investigation was carried out to check the absorption and stability characteristics of sodium amazolene (Coomassie Blue) from different lot numbers and to ascertain whether or not it could be combined with indocyanine green (Cardio Green) in vitro without altering the physical characteristics of either dye. These studies demonstrate that a linear relationship exists between optical density and dye concentration for each batch of dye studied, that sodium amazolene is stable in vitro, and that sodium amazolene can be combined with indocyanine green without altering the absorption characteristics of either dye.
The use of the indicator dilution technique for the measurement of blood (or plasma) volume and cardiac output is a standard procedure in many clinical and experimental laboratories. An indicator substance must possess different physical properties if it is to be used for consecutive measurements of plasma volume Than if it is to be used for multiple cardiac output determinations within a relatively short period of time. At the present time, a single substance is not available which could be used for consecutive, simultaneous estimations of these two physiological variables.
It is not unreasonable to suggest that two currently acceptable indicator substances, sodium amazolene* and indocyanine green (Cardio Green -Hynson, Wescott and Dunning), which possess different physical properties, could be injected simultaneously and their concentrations detected by standard photometric techniques. Other investigators have indeed used these two dyes together to measure blood flows in human subjects (Zitnik et al., 1965) . In these experiments, the dyes were injected and sampled separately at different sites. If, however, these two dyes could be mixed together in vitro without altering the * Sodium amazolene (Coomassie Blue-Imperial Chemical Industries Ltd., England) supplied through the courtesy of Ayerst Laboratories, New York, New York. stability and absorption characteristics of either indicator they could be injected simultaneously as a bolus, thus preventing a time lag between injections.
This investigation was carried out to check the stability and absorption characteristics of sodium amazolene in vitro and to determine if it and indocyanine green could be mixed together in vitro without altering the absorption characteristics of either dye.
METHODS
At hourly intervals for 6 hours, aliquots of a stock solution of sodium amazolenef (2.0 per cent, 20 mg/ml) were diluted with distilled water and their absorption spectra scanned (wavelength scan 400-900 m^) on a Beckman DK-2 ratio recording spectrophotometer. Whenever this spectrophotometer was used, it was allowed to stabilize for a minirrmm period of 3 hours prior to use. Distilled water in a matched quartz cuvette was used as the reference cell. Prior to the scanning procedure, the instrument was balanced using the same quartz cuvettes filled with distilled water.
The same spectrophotometer was used to study the stability of a 0.001 per cent aqueous solution of sodium amazolene. The instrument was set at fTwo different lot numbers (A6847JJ and A6821JJ) were used in this investigation. the wavelength of maYimnm light absorption for the dye and the aliquot introduced into the sample compartment at regular intervals for 6 hours.
The following approach was used to see if sodium amazolene and indocyanine green could be mixed together in vitro without altering the light absorption characteristics of either dye. A spectrum scan of sodium amazolene (2.5 mg/1. water) and indocyanine green (2.5 mg/1. water) was carried out between 400 and 900 tap. This BRITISH JOURNAL OF ANAESTHESIA procedure was repeated with other mixtures of varying concentrations of sodium amazolene and indocyanine green.
Since it is the concentration of sodium amazolene in plasma that is used as the figure for calculating plasma volume, it was thought desirable to see if its absorption spectrum in plasma was altered by the presence of indocyanine green. ThuSj a spectral scan of sodium amazolene (2.5 mg/1. plasma) and indocyanine green (2.5 mg/1. plasma) was carried out between 400 and 900 m^. 
900
The procedure used for determining the stability of the spectrophotometer has been previously described (Micbie, Goldsmith and Mason, 1962) .
RESULTS
Spectrum scans of aqueous dilutions of stock solutions (2 per cent) of sodium amazolene from two different lot numbers showed that the maximum peak absorption of the dye, in the spectral region 400-900 m^, is located at 570 m^ ( fig. 1 ). This is in direct agreement with the non-documented reports of other investigators (Taylor and Thorp, 1959) . The wavelength of peak absorption for this dye did not deviate from 570 m^ during the 6-hour study interval. The optical density of a given aliquot of the dye at a fixed wavelength of 570 ni[x did not change with the passage of time. Figure 2 depicts changes in the optical density of various concentrations of sodium amazolene in distilled water. It can be seen from these data that the absorption characteristics of sodium amazolene obey the Beer-Lambert Law* at a wavelength of 570 m^. Figure 3 shows a spectrum scan of sodium amazolene and indocyanine green mixed together. The peak attributed to indocyanine green did not shift; however, the maximum peak of light absorption ascribed to sodium amazolene shifted approximately 10 m^ towards a longer wavelength. Further evidence of the influence of indocyanine green is shown by the fact that the optical density of the mixture at 570 mp deviated from linearity (insert, figure 3) . For clinical applications, the amount of sodium amazolene injected for each determination (0.4-0.8 mg/kg body weight) is considerably higher than that of indocyanine green (2.5-5.0 mg/determination). At these relative concentrations (sodium amazolene approximately 12 times that of indocyanine green) the contribution of indocyanine green to the optical density of the mixture at a wavelength of 570 mî s negligible (<0.01 per cent).
The absorption spectrum of sodium amazolene in plasma (between 400 and 900 my.) was unaltered by the presence of indocyanine green.
DISCUSSION
In 1958 sodium amazolene was introduced for the measurement of plasma volume and related cardiovascular parameters in human subjects with satisfactory results (Allen, Conn and Junkin, 1959; Armstrong and Payne, 1960; Bousvaros et al., 1963; Bruce and Shillingford, 1962; Frederick and Fekete, 1960; Hoffman and Abraham, 1961; Marshall et al., 1960; Martin, 1961; Martin and Fuller, 1963; McDonald, 1959; McGregor, Sekelj and Adam, 1961; Oakley et al., 1960; Payne, 1964; Payne and Armstrong, 1962; Schlant, Tsagaris and Robertson, 1960; Sekelj and McGregor, 1961; Taylor and Shillingford, 1959) . Whereas the half-life of sodium amazolene in vivo is too long to make this dye useful for serial determinations of cardiac output within a relatively short period of time (decay rate= 0.016), it is quite acceptable for use in estimating the plasma volume where routinely fewer determinations are made during a given period of time (Martin, 1961; Oakley et al., 1960) . Sodium amazolene reaches an equilibrium distribution in plasma in 3.5 minute (Martin, 1961) , thereby negating the need to take periodic blood samples and to prepare semi-logarithmic plots of the plasma dye concentrations versus time. The dye persists in the circulation longer than indocyanine green but not nearly as long as Evans Blue dye (Martin, 1961; Martin and Fuller, 1963) . Thus, multiple determinations of plasma volume can be made within a several-hour study interval. In addition, this dye has other characteristics which make it well suited for this application. It is nontoxic (Frederick and Fekete, 1960; Hoffman and Abraham, 1961; Martin, 1961; McGregor, Sekelj and Adam, 1961; Taylor and Shillingford, 1959; Taylor and Thorp, 1959) in doses of 200-1000 mg (Taylor and Shillingford, 1959) . In fact, some investigators report that sodium amazolene is definitely less toxic than Evans Blue dye (Frederick and Fekete, 1960; Hoffman and Abraham, 1961; Taylor and Thorp, 1959) . The dye does not stain the skin as does Evans Blue dye (Frederick and Fekete, 1960; Hoffman and Abraham, 1961; Taylor and Thorp, 1959) . Small doses of sodium amazolene (0.4-0.8 mg/kg body weight) are used for each determination (Fredcrick and Fekete, 1960; McGregor, Sekelj and Adam, 1961) . It can be sterilized by autodaving (Taylor and Thorp, 1959) . There is complete clearance of the dye from the body in 12 hours (Oakley et al., 1960) . The data presented in this paper confirm the statements of Payne and Armstrong (1962) and Taylor and Thorp (1959) that sodium amazolene obeys the Beer-Lambert Law in aqueous solutions and that the dye is stable in vitro. Indocyanine green was introduced by Fox and Wood in 1957 as an acceptable indicator for serial cardiac output determinations (Fox and Wood, 1957) . This substance is ideally suited for consecutive measurements of cardiac output because it disappears rapidly from the circulation (mean half-time of disappearance curves is 7.8 minutes) (Wheller, Cranston and Meltzer, 1958) . The dye is non-toxic (Wood, Swan and Helmholz, 1957) and variations in the oxygen saturation of the blood have no effect on the indicator dilution curves because indocyanine green has its maximum peak absorption of light in whole blood at 800 m^, an isobestic point of reduced and oxygenated haemoglobin (Fox et al., 1957; Fox and Wood, 1957) . Although indocyanine green has been reported by Michie and colleagues to be unstable in aqueous solution over a period of hours, the dye continued to obey the BeerLambert Law (Michie, Goldsmith and Mason, 1962) . The dye can, however, be used for sequential estimations of cardiac output if correction is made for the changing light absorption by construction of a calibration curve each time the dye is used (Michie, Goldsmith and Mason, 1962) .
Commercial instrumentation is available for determining the concentration of indocyanine green or sodium amazolene individually in blood; however, a single instrument for simultaneously determining both dye concentrations is not currently available. In order to measure cardiac output and plasma volume, both dyes would be mixed together in a syringe and injected simultaneously. The indicator dilution curve representative of cardiac output would be inscribed using a conventional cuvette densitometer (monochromatic for the peak absorption of indocyanine green). Three and one-half minutes after the injection, a sample of blood would be withdrawn and the concentration of sodium amazolene measured in a spectrophotometer. Since the presence of indocyanine green in plasma does not alter the peak absorption of sodium amazolene, the readings taken of the spectrophotometer will reflect only the concentration of sodium amazolene in the plasma. Deane, Phinney and McLean (1966) have recently reported a simplified technique for the spectrophotometric determination of sodium amazolene.
This investigation has demonstrated that aqueous solutions of sodium amazolene are stable, and that there are no differences in light absorption characteristics (wavelength=570 m^) between different lot numbers of the dye. Sodium amazolene can be combined with indocyanine green without significantly altering the light absorption characteristics of eidier indicator substance in plasma or in an aqueous solution.
